DURHAM, N.C.--(BUSINESS WIRE)--MED-EL USA announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s cochlear implant system for single-sided deafness (SSD) and ...
11-year-old DuJuan Broadus is the first U.S. patient to receive a MED-EL FLEX34 cochlear implant, designed for those with a larger cochlea. The new implant allows for a wider range of frequencies, ...
A study from Ann & Robert H. Lurie Children's Hospital of Chicago found that children with a MED-EL Synchrony cochlear implant device can undergo MRI safely, with no discomfort and reduced need for ...
The U.S. Food and Drug Administration has approved an expanded indication for MED-EL (Medical Electronics) cochlear implants for children ages 7 months and older with bilateral sensorineural hearing ...
The cochlear implant systems that we know today with small designs and built-in future-ready technology have come a long way since Austrian scientists Ingeborg and Erwin Hochmair began working on ...
The FDA has approved SYNCHRONY and SYNCHRONY 2 (MED-EL) cochlear implant systems for single-sided deafness and asymmetric hearing loss. The Food and Drug Administration (FDA) has approved SYNCHRONY ...
DURHAM, N.C., April 29, 2026--(BUSINESS WIRE)--Hearing implant leader MED-EL USA is announcing two upcoming symposia at CI2026, the annual meeting of the American Cochlear Implant Association (ACIA) ...
Patients with single-sided deafness or asymmetric hearing loss often have associated problems like identifying where sounds originate, maintaining balance, speech recognition and hearing in complex ...
MED-EL’s are the First and Only Cochlear Implants to Be Granted Indications for Traditionally Underserved Population MED-EL Cochlear Implant Systems, including the recently FDA-approved SYNCHRONY 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results